Laurens Wim, Deleersnijder Dries, Dendooven Amélie, Lerut Evelyne, De Vriese An S, Dejagere Tom, Helbert Mark, Hellemans Rachel, Koshy Priyanka, Maes Bart, Pipeleers Lissa, Van Craenenbroeck Amaryllis H, Van Laecke Steven, Vande Walle Johan, Coutteneye Marie M, De Meester Johan, Sprangers Ben
Department of Nephrology and Dialysis, AZ Nikolaas Hospital, Sint-Niklaas, Belgium.
Department of Microbiology, Immunology and Transplantation, Laboratory of Molecular Immunology, Rega Institute, KU Leuven, Leuven, Belgium.
Clin Kidney J. 2022 Jan 29;15(7):1361-1372. doi: 10.1093/ckj/sfac033. eCollection 2022 Jul.
The Flemish Collaborative Glomerulonephritis Group (FCGG) registry is the first population-based native kidney biopsy registry in Flanders, Belgium. In this first analysis, we report on patient demographics, frequency distribution and incidence rate of biopsied kidney disease in adults in Flanders.
From January 2017 to December 2019, a total of 2054 adult first native kidney biopsies were included. A 'double diagnostic coding' strategy was used, in which every biopsy sample received a histopathological and final clinical diagnosis. Frequency distribution and incidence rate of both diagnoses were reported and compared with other European registries.
The median age at biopsy was 61.1 years (interquartile range, 46.1-71.7); male patients were more prevalent (62.1%) and biopsy incidence rate was 129.3 per million persons per year. Immunoglobulin A nephropathy was the most frequently diagnosed kidney disease (355 biopsies, 17.3% of total) with a similar frequency as in previously published European registries. The frequency of tubulointerstitial nephritis (220 biopsies, 10.7%) and diabetic kidney disease (154 biopsies, 7.5%) was remarkably higher, which may be attributed to changes in disease incidence as well as biopsy practices. Discordances between histopathological and final clinical diagnoses were noted and indicate areas for improvement in diagnostic coding systems.
The FCGG registry, with its 'double diagnostic coding' strategy, provides useful population-based epidemiological data on a large Western European population and allows subgroup selection for future research.
佛兰芒协作性肾小球肾炎研究组(FCGG)登记处是比利时佛兰德斯地区首个基于人群的原发性肾活检登记处。在首次分析中,我们报告了佛兰德斯地区成人活检肾病的患者人口统计学特征、频率分布和发病率。
纳入2017年1月至2019年12月期间共2054例成人首次原发性肾活检病例。采用“双重诊断编码”策略,即每个活检样本都有组织病理学诊断和最终临床诊断。报告了两种诊断的频率分布和发病率,并与其他欧洲登记处进行了比较。
活检时的中位年龄为61.1岁(四分位间距为46.1 - 71.7岁);男性患者更为常见(62.1%),活检发病率为每年每百万人129.3例。免疫球蛋白A肾病是最常诊断出的肾病(355例活检,占总数的17.3%),其频率与之前发表的欧洲登记处相似。肾小管间质性肾炎(220例活检,10.7%)和糖尿病肾病(154例活检,7.5%)的频率显著更高,这可能归因于疾病发病率的变化以及活检操作的改变。注意到组织病理学诊断与最终临床诊断之间存在不一致,这表明诊断编码系统有待改进。
FCGG登记处以其“双重诊断编码”策略,提供了有关大量西欧人群的有用的基于人群的流行病学数据,并为未来研究提供了亚组选择。